01.06.10 Martinsried – Researchers from the Max Planck Insitute for Biochemistry have presented a novel technique that enables them to map the entire pattern of N-glycosylation (linking a sugar to the amino acid asparagine) and the...
more
31.05.10 Monheim/Sao Paulo – German Bayer CropScience has entered a research collaboration with the Brazilian Center for Sugarcane Technology (CTC, www.ctc.com.br) aimed at developing sugarcane varieties with higher sugar content. The...
more
27.05.10 Ingelheim/Ghent - Boehringer Ingelheim has selected an antibody candidate from its $265 million worldwide research programme, resulting from the Alzheimer's research collaboration with Belgian Ablynx NV, signed in January 2007....
more
19.05.10 Ingelheim/Ridgefield – Boehringer Ingelheim has presented promising Phase III results demonstrating that its drug candidate flibanserin significantly increases satisfying sexual events (SSE) and sexual desire in pre-menopausal...
more
13.05.10 Martinsried – SuppreMol GmbH has enrolled the first patient in a Phase Ib/IIa clinical trial with SM101, a treatment for Idiopathic Thrombocytopenic Purpura (ITP). Up to 36 patients will receive 4 weekly doses of the recombinant,...
more
